Freestone Grove Partners »

Quest Diagnostics Incorporated shares owned by Freestone Grove Partners

Quarter-by-quarter ownership of Quest Diagnostics Incorporated (DGX) shares owned by Freestone Grove Partners from 13F filings

Historical chart of Freestone Grove Partners investment in Quest Diagnostics Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Quest Diagnostics Incorporated held by Freestone Grove Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Quest Diagnostics Incorporated by Freestone Grove Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $54M 309k 173.53

More positions owned by Freestone Grove Partners

Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Amazon (AMZN)
Boston Scientific Corporation (BSX)
Ametek (AME)
Encana Corporation (OVV)
First Horizon National Corporation (FHN)
Charles Schwab Corporation (SCHW)
Anthem (ELV)
MasTec (MTZ)
Fortune Brands (FBIN)
Xcel Energy (XEL)
Lennar Corp Cl A (LEN)
Martin Marietta Materials (MLM)
Danaher Corporation (DHR)

View all positions for Freestone Grove Partners

Top funds holding Quest Diagnostics Incorporated

Vanguard Group
BlackRock
State Street Corporation
Jpmorgan Chase & Co
Robeco Investment Management
Geode Capital Management
Victory Capital Management
Dimensional Fund Advisors
Grantham, Mayo, Van Otterloo & Co
Wells Fargo & Company
Goldman Sachs Group
Invesco
Edgepoint Investment
Davis Selected Advisers
Wellington Management Company

View all funds holding Quest Diagnostics Incorporated